Abstract
Influence of metformin intake on the risk of bladder cancer in type 2 diabetes patients
Highlights
Objective The aim of this study is to look at the influence of metformin intake and duration, on urinary bladder cancer (UBC) risk, with sulfonylurea (SU) only users as control using a new-user design (inception cohort)
Submit your manuscript to BioMed Central and take full advantage of:
Summary
Influence of metformin intake on the risk of bladder cancer in type 2 diabetes patients. Maria (Mieke) Goossens1*, Frank Buntinx[1], Maurice Zeegers[2], Annemariek Driessen[3], Marie De Bruin[3], Frank De Vries[3]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
